Literature DB >> 6418684

HSV-1 shedding by lontophoresis of 6-hydroxydopamine followed by topical epinephrine.

Y Shimomura, L P Gangarosa, M Kataoka, J M Hill.   

Abstract

The development of an animal model for herpes simplex virus (HSV) reactivation is of great importance in studying HSV latency, reactivation, recurrence, and chemotherapy. Epinephrine iontophoresis to the cornea can induce HSV type 1 (HSV-1) ocular shedding from latently infected rabbits. In the present experiment, adrenergic induction of HSV-1 was enhanced by iontophoresis of 6-hydroxydopamine (6-HD) to the rabbit cornea followed by topical epinephrine to the eye. Eye swabs were utilized to determine HSV-1 shedding in the tear film. The combined treatment was performed on selected days during 66 to 292 days (mean 159) postinoculation, resulting in HSV-1 shedding from 100% of the eyes (17/17) within 6 days after the 6-HD treatment. The onset of initial shedding was as early as day 1. The highest frequency (93%) of shedding occurred on day 2. The mean duration of consecutive HSV-1 sheddings was 3.2 days. The importance of prior spontaneous HSV-1 ocular sheddings relative to this induced HSV-1 reactivation system also was demonstrated. Latently infected rabbits that shed virus spontaneously could be induced to shed virus at a much higher frequency and for a longer duration than rabbits that had not shed virus spontaneously. Iontophoresis of 6-HD produced ocular adrenergic supersensitization and with topical epinephrine it induced HSV-1 ocular shedding in 100% of eyes. This new model of induced HSV-1 ocular shedding will be useful for investigation of adrenergic mechanisms that may be involved in HSV reactivation and recurrence.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418684

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

1.  Detection of latency-related viral RNAs in trigeminal ganglia of rabbits latently infected with herpes simplex virus type 1.

Authors:  D L Rock; A B Nesburn; H Ghiasi; J Ong; T L Lewis; J R Lokensgard; S L Wechsler
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

2.  The proportion of trigeminal ganglionic neurons expressing herpes simplex virus type 1 latency-associated transcripts correlates to reactivation in the New Zealand rabbit ocular model.

Authors:  Y J Gordon; E G Romanowski; T Araullo-Cruz; P R Kinchington
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-10       Impact factor: 3.117

3.  Herpes simplex virus type 1 strain KOS-63 does not cause acute or recurrent ocular disease and does not reactivate ganglionic latency in vivo.

Authors:  W G Stroop; M C Banks
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

4.  Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy.

Authors:  P A Asbell
Journal:  Trans Am Ophthalmol Soc       Date:  2000

5.  Alphaherpesvirus DNA replication in dissociated human trigeminal ganglia.

Authors:  Randall J Cohrs; Hussain Badani; Nathan Bos; Charles Scianna; Ian Hoskins; Nicholas L Baird; Don Gilden
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 2.643

Review 6.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

7.  Vaccine therapy for ocular herpes simplex virus (HSV) infection: periocular vaccination reduces spontaneous ocular HSV type 1 shedding in latently infected rabbits.

Authors:  A B Nesburn; R L Burke; H Ghiasi; S Slanina; S Bahri; S L Wechsler
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

8.  Evaluation of lithium as an inhibitory agent of herpes simplex virus in cell cultures and during reactivation of latent infection in rabbits.

Authors:  M D Trousdale; Y J Gordon; A C Peters; T I Gropen; E Nelson; A B Nesburn
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 9.  Molecular biology of herpes simplex virus type 1 latency in the nervous system.

Authors:  I Steiner; P G Kennedy
Journal:  Mol Neurobiol       Date:  1993       Impact factor: 5.590

10.  In vivo and in vitro reactivation impairment of a herpes simplex virus type 1 latency-associated transcript variant in a rabbit eye model.

Authors:  M D Trousdale; I Steiner; J G Spivack; S L Deshmane; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.